Last reviewed · How we verify

NCT04908761

Quadratus Lumborum Block After Living Donor Kidney Transplantation

Completed NA Last updated 27 December 2022
What this trial tests

NA trial testing Transmuscular quadratus lumborum block in Analgesia in 88 participants. Completed in 28 May 2022.

Timeline
3 June 2021
Primary endpoint
18 May 2022
28 May 2022

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment88
Start date3 June 2021
Primary completion18 May 2022
Estimated completion28 May 2022
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

19 and older, any sex, with Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the postoperative analgesic effect of quadratus lumborum block in patient undergoing a living donor kidney transplant under general anesthesia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Anterior quadratus lumborum block for analgesia after living-donor renal transplantation: a double-blinded randomized controlled trial.
    Kim Y, Kim JT, Yang SM, Kim WH, et al · · 2024 · cited 12× · PMID 37704438 · DOI 10.1136/rapm-2023-104788

Verify or expand the search:

Other recruiting trials for Analgesia

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04908761.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing